Articles by James Calloway
GSK Gains on EU Asthma Drug Approval and £450M Share Repurchase
GSK shares advanced after the European Commission approved its asthma drug Exdensur and the company launched a £450 million share repurchase. New data also highlighted the effectiveness of its RSV vaccine.
Glencore Announces $2 Billion Payout, Advances Congo Copper Expansion
Glencore shares gained approximately 3% in London trading following the release of its 2025 financial results, which included a proposed $2 billion cash return to shareholders and progress on a major copper expansion project in the Democratic Republic of Congo.
BAE Systems Stock Surges on Strong Earnings, Record Order Book
BAE Systems shares surged more than 6% in early London trading following robust annual results, including a 12% rise in underlying operating profit and a record order backlog of £83.6 billion.
Santos Announces Workforce Reduction, Maintains Outlook Amid Profit Shortfall
Santos shares fell following a full-year profit miss, with the company announcing a 10% reduction in its workforce and a portfolio review. The energy producer maintained its 2026 guidance and declared a final dividend.
Fortescue Gains as Wyloo Mine Enters Public Review, Results Loom
Fortescue shares advanced slightly as regulators began a public feedback period for its proposed Wyloo North iron ore mine. Investors are focused on the upcoming comment deadline and the company's half-year financial report.
Pro Medicus Shares Slide Amid Insider Purchases, Brokers Cut Targets
Pro Medicus shares declined further despite insider buying, with the stock down 43% year-to-date. The medical imaging software firm posted strong half-year results but faces near-term headwinds.
Wesfarmers Gains Ahead of Key Half-Year Report
Wesfarmers Ltd edged higher ahead of its half-year financial report, with the market focused on retail performance and forward outlook. The broader ASX 200 index also advanced.
Telstra Gains Ahead of Key Earnings, Dividend Dates
Telstra shares closed slightly higher as the market anticipates Thursday's half-year results and the upcoming ex-dividend trading period. Investors are focused on dividend announcements and mobile segment performance.
Woodside Energy Reserves Dip Ahead of Annual Results
Woodside Energy's proved reserves declined year-over-year, but technical updates and project approvals added 134.1 MMboe excluding production. The market now focuses on the upcoming annual report.
NAB Shares Surge to Record High on Strong Q1 Earnings, Capital Levels in Focus
National Australia Bank shares climbed 4% to a record close after posting robust first-quarter results, though a dip in its capital ratio has drawn market attention.
BHP Retreats from Record High as Investors Eye Dividend Dates and Copper Strategy
BHP Group declined 0.9% in Sydney trading, pulling back from a record high set after strong half-year results. The miner declared a 73-cent interim dividend and announced a major silver streaming agreement while raising its copper production target.
Aviva Gains Ahead of Key March Earnings, Investors Eye Capital Returns
Aviva's stock advanced 1.3% to 636.2 pence, outpacing the broader market ahead of its March 5 earnings release. Investors are scrutinizing the insurer's capital return strategy and retail investment push.